Tata India Pharma and Healthcare Fund · Regular · Growth
NAV
₹33.7044
as of 31 Jul 2026
Expense Ratio
2.11%
AUM
₹1,359 Cr
Lumpsum returns (CAGR)
- 1Y
- +7.96%
- 3Y
- +19.33%
- 5Y
- +13.71%
- Since Inception
- +12.16%
SIP returns (XIRR)
- 1Y
- +20.15%
- 3Y
- +15.33%
- 5Y
- +17.41%
- Since Inception
- +16.71%
What history actually did — last 10 years (Aug 2016 – Jul 2026)
A ₹5,000 monthly SIP for the last 10 years (Aug 2016 – Jul 2026)
Real NAV backtest
A ₹5,000 monthly SIP would be worth ₹14,76,646 today — ₹5,95,000 invested, 17.5% XIRR.
₹5,95,000
Invested
₹14,76,646
Value today
17.5%
XIRR (p.a.)
A ₹1,00,000 lumpsum, the last 10 years (Aug 2016 – Jul 2026)
Real NAV backtest
₹1,00,000 invested 10 years ago would be ₹3,40,676 today (13.1% CAGR).
A regular withdrawal plan (SWP)
Real NAV backtest
A ₹10,00,000 corpus withdrawing ₹5,000/month since Aug 2016 would still hold ₹19,30,110.
Fund vs Benchmark (TRI)
Same SIP, benchmark total-return index
The same SIP would be worth ₹14,76,646 in this fund vs ₹12,17,407 in the benchmark — outperformance of ₹2,59,239.
Buying the worst day
Real NAV backtest
₹1,00,000 invested on the worst market day of the last 10 years (Aug 2016 – Jul 2026) (22 Mar 2020) would be ₹4,07,427 today (4.07×).
Historical simulation using actual published NAVs for the stated period. Past performance may or may not be sustained in the future. Not investment advice.
Risk Metrics
Trailing 1 year, annualised0.17
Sharpe Ratio
+0.04
Alpha
0.22
Beta
0.16
Sortino
13.22%
Std Dev
-11.85%
Max Drawdown
Performance Comparison
Thinking about Tata India Pharma and Healthcare Fund · Regular · Growth?
Talk to our AMFI-registered team — free, no pressure. We'll help you see if this fund fits your goals.
Compare with Similar Funds
Fund Details
Available transactions
Portfolio holdings
- 1Sun Pharmaceutical Industries Ltd8.51%
- 2Max Healthcare Institute Ltd5.68%
- 3Healthcare Global Enterprises Ltd5.52%
- 4Divi Laboratories Ltd5.12%
- 5Abbott India Ltd4.97%
- 6Cipla Ltd4.77%
- 7Apollo Hospitals Enterprise Ltd4.61%
- 8Rainbow Childrens Medicare Ltd4.42%
- 9Dr Reddys Laboratories Ltd4.26%
- 10Glaxosmithkline Pharmaceuticals Ltd4.12%
Investment Objective
Tata India Pharma and Healthcare Fund · Regular · Growth invests in stocks from a specific sector or theme, offering concentrated exposure to a particular area of the economy. These funds carry sector-specific risks but can deliver significant returns when the underlying sector performs well.
About This Fund
Tata India Pharma and Healthcare Fund · Regular · Growth is a Sectoral / Thematic mutual fund offered by Tata Mutual Fund. The fund has been operational for over 10 years. It manages assets worth ₹1,359 Cr, reflecting investor confidence in the fund's strategy. It benchmarks its performance against BSE Healthcare. The current expense ratio is 2.11%.
Who Should Invest?
- •Aggressive investors comfortable with significant short-term volatility
- •Investors with a long-term horizon of 7+ years who can ride out market cycles
- •SIP investors who can benefit from rupee cost averaging during market fluctuations